Showing 1 - 5 results of 5 for search 'Francesco Pignatti', query time: 0.02s
Refine Results
-
1
The European Medicines Agency Review of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma by Julio Delgado, Irene Papadouli, Sinan B. Sarac, Alexandre Moreau, Doris Hovgaard, Christian Gisselbrecht, Harald Enzmann, Francesco Pignatti
Published 2021-12-01
Article -
2
The European Medicines Agency Review of Crizanlizumab for the Prevention of Recurrent Vaso-Occlusive Crises in Patients With Sickle Cell Disease by Julio Delgado, Caroline Voltz, Milena Stain, Tuomo Lapveteläinen, Susanne Urach, Johanna Lähteenvuo, Karri Penttilä, Christian Gisselbrecht, Harald Enzmann, Francesco Pignatti
Published 2021-07-01
Article -
3
The European Medicines Agency Review of Luspatercept for the Treatment of Adult Patients With Transfusion-dependent Anemia Caused by Low-risk Myelodysplastic Syndromes With Ring Si... by Julio Delgado, Caroline Voltz, Milena Stain, Ewa Balkowiec-Iskra, Brigitte Mueller, Johanna Wernsperger, Iwona Malinowska, Christian Gisselbrecht, Harald Enzmann, Francesco Pignatti
Published 2021-08-01
Article -
4
P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS by Sjoerd Hermans, Yvette van Norden, Erik van Werkhoven, Avinash Dinmohamed, Peter Huijgens, Gert Ossenkoppele, Gerwin Huls, Bob Löwenberg, Thomas Pabst, Dimitri Breems, Douwe Postmus, Francesco Pignatti, Jurjen Versluis, Jan Cornelissen
Published 2023-08-01
Article -
5
Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial by Niek G. van der Maas, Jurjen Versluis, Kazem Nasserinejad, Joost van Rosmalen, Thomas Pabst, Johan Maertens, Dimitri Breems, Markus Manz, Jacqueline Cloos, Gert J. Ossenkoppele, Yngvar Floisand, Patrycja Gradowska, Bob Löwenberg, Gerwin Huls, Douwe Postmus, Francesco Pignatti, Jan J. Cornelissen
Published 2024-03-01
Article